ACTIVE SUBSTANCE / INN

IODINE (131I) OMBURTAMAB

Brand name(s): Omblastys
EMA LISTED
REFUSED
Neuroblastoma
ACTIVE SUBSTANCE
Iodine (131I) Omburtamab
REGULATORS
EMA
SPONSORS / MAH
Y-Mabs Therapeutics A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OmblastysY-Mabs Therapeutics A/SRefusedNeuroblastoma

FULL INTELLIGENCE ON IODINE (131I) OMBURTAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →